Meeting
2014 ASCO Annual Meeting
Profiling of 1,350 neuroendocrine tumors for identification of multiple potential drug targets.
Authors
Igor A. Astsaturov
Fox Chase Cancer Center, Philadelphia, PA
Igor A. Astsaturov , Steven J. Cohen , Paul F. Engstrom , Sherri Z. Millis
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal (Noncolorectal) Cancer
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Neuroendocrine/Carcinoid
Citation
J Clin Oncol 32:5s, 2014 (suppl; abstr 4113)
DOI
10.1200/jco.2014.32.15_suppl.4113
Abstract #
4113
Poster Bd #
200
Abstract Disclosures
Similar Posters
Poster
2014 Gastrointestinal Cancers Symposium
Profiling of a global cohort of 1,250 neuroendocrine tumors to identify multiple potential drug targets.
First Author: Igor A. Astsaturov
Poster
2018 ASCO Annual Meeting
Seventeen percent of NGS 50 gene panel variants are not expressed in RNAseq.
First Author: Razelle Kurzrock
Poster
2014 Genitourinary Cancers Symposium
Molecular profiling of advanced refractory prostate cancer.
First Author: Rebecca A. Feldman
Poster
2017 Gastrointestinal Cancers Symposium
Parallel sequencing of a 50 genes panel in metastatic colorectal cancer (MCRC) patients (pts) treated with intensive first-line FIr-B/FOx triplet chemotherapy plus bevacizumab (BEV): Preliminary data and clinical outcome.
First Author: Gemma Bruera